JNJ Restructuring Expected to Impact DePuy Synthes

Johnson & Johnson (JNJ), parent company of DePuy Synthes, will undertake restructuring actions in its Medical Devices business, including changes to the orthopaedics segment. Surgery and cardiovascular segments are also included in the expected impact. Orthopaedic revenue represents over one-third (5%) of JNJ’s overall Medical Devices...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us